Insulin glargine, marketed under the names Lantus among others, is a long-acting insulin, used in the treatment of type I and type II diabetes.
The report focuses on the Insulin Glargine market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.
Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Insulin Glargine market.
Major Players in the Insulin Glargine market are:
United Labs
Gan & Lee
Eli Lilly & Company
Tonghua Dongbao
Sanofi
Viatris
On the basis of types, the Insulin Glargine market is primarily split into:
Vials
Cartridges
Prefilled Filled Syringe
On the basis of applications, the market covers:
Type 1 Diabetes Treatment
Type 2 Diabetes Treatment
Major Regions or countries covered in this report:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2029
Global Insulin Glargine Market Research Report 2022 - Market Size, Current Insights and Development Trends
Table of Content
1 Insulin Glargine Market Overview
1.1 Product Overview and Scope of Insulin Glargine Market
1.2 Insulin Glargine Market Segment by Type
1.2.1 Global Insulin Glargine Market Sales and CAGR (%) Comparison by Type (2017-2029)
1.3 Global Insulin Glargine Market Segment by Application
1.3.1 Insulin Glargine Market Consumption (Sales) Comparison by Application (2017-2029)
1.4 Global Insulin Glargine Market, Region Wise (2017-2029)
1.5 Global Market Size (Revenue) of Insulin Glargine (2017-2029)
1.5.1 Global Insulin Glargine Market Revenue Status and Outlook (2017-2029)
1.5.2 Global Insulin Glargine Market Sales Status and Outlook (2017-2029)
1.6 Influence of Regional Conflicts on the Insulin Glargine Industry
1.7 Impact of Carbon Neutrality on the Insulin Glargine Industry
2 Insulin Glargine Market Upstream and Downstream Analysis
2.1 Insulin Glargine Industrial Chain Analysis
2.2 Key Raw Materials Suppliers and Price Analysis
2.3 Key Raw Materials Supply and Demand Analysis
2.4 Market Concentration Rate of Raw Materials
2.5 Manufacturing Process Analysis
2.6 Manufacturing Cost Structure Analysis
2.6.1 Labor Cost Analysis
2.6.2 Energy Costs Analysis
2.6.3 R&D Costs Analysis
2.7 Major Downstream Buyers of Insulin Glargine Analysis
2.8 Impact of COVID-19 on the Industry Upstream and Downstream
3 Players Profiles
3.1 United Labs
3.1.1 United Labs Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Product Profiles, Application and Specification
3.1.3 Insulin Glargine Market Performance (2017-2022)
3.1.4 Business Overview
3.2 Gan & Lee
3.2.1 Gan & Lee Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Product Profiles, Application and Specification
3.2.3 Insulin Glargine Market Performance (2017-2022)
3.2.4 Business Overview
3.3 Eli Lilly & Company
3.3.1 Eli Lilly & Company Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Product Profiles, Application and Specification
3.3.3 Insulin Glargine Market Performance (2017-2022)
3.3.4 Business Overview
3.4 Tonghua Dongbao
3.4.1 Tonghua Dongbao Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Product Profiles, Application and Specification
3.4.3 Insulin Glargine Market Performance (2017-2022)
3.4.4 Business Overview
3.5 Sanofi
3.5.1 Sanofi Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Product Profiles, Application and Specification
3.5.3 Insulin Glargine Market Performance (2017-2022)
3.5.4 Business Overview
3.6 Viatris
3.6.1 Viatris Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Product Profiles, Application and Specification
3.6.3 Insulin Glargine Market Performance (2017-2022)
3.6.4 Business Overview
4 Global Insulin Glargine Market Landscape by Player
4.1 Global Insulin Glargine Sales and Share by Player (2017-2022)
4.2 Global Insulin Glargine Revenue and Market Share by Player (2017-2022)
4.3 Global Insulin Glargine Average Price by Player (2017-2022)
4.4 Global Insulin Glargine Gross Margin by Player (2017-2022)
4.5 Insulin Glargine Market Competitive Situation and Trends
4.5.1 Insulin Glargine Market Concentration Rate
4.5.2 Insulin Glargine Market Share of Top 3 and Top 6 Players
4.5.3 Mergers & Acquisitions, Expansion
5 Global Insulin Glargine Sales, Revenue, Price Trend by Type
5.1 Global Insulin Glargine Sales and Market Share by Type (2017-2022)
5.2 Global Insulin Glargine Revenue and Market Share by Type (2017-2022)
5.3 Global Insulin Glargine Price by Type (2017-2022)
5.4 Global Insulin Glargine Sales, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Insulin Glargine Sales, Revenue and Growth Rate of Vials (2017-2022)
5.4.2 Global Insulin Glargine Sales, Revenue and Growth Rate of Cartridges (2017-2022)
5.4.3 Global Insulin Glargine Sales, Revenue and Growth Rate of Prefilled Filled Syringe (2017-2022)
6 Global Insulin Glargine Market Analysis by Application
6.1 Global Insulin Glargine Consumption and Market Share by Application (2017-2022)
6.2 Global Insulin Glargine Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Insulin Glargine Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Insulin Glargine Consumption and Growth Rate of Type 1 Diabetes Treatment (2017-2022)
6.3.2 Global Insulin Glargine Consumption and Growth Rate of Type 2 Diabetes Treatment (2017-2022)
7 Global Insulin Glargine Sales and Revenue Region Wise (2017-2022)
7.1 Global Insulin Glargine Sales and Market Share, Region Wise (2017-2022)
7.2 Global Insulin Glargine Revenue and Market Share, Region Wise (2017-2022)
7.3 Global Insulin Glargine Sales, Revenue, Price and Gross Margin (2017-2022)
7.4 United States Insulin Glargine Sales, Revenue, Price and Gross Margin (2017-2022)
7.5 Europe Insulin Glargine Sales, Revenue, Price and Gross Margin (2017-2022)
7.6 China Insulin Glargine Sales, Revenue, Price and Gross Margin (2017-2022)
7.7 Japan Insulin Glargine Sales, Revenue, Price and Gross Margin (2017-2022)
7.8 India Insulin Glargine Sales, Revenue, Price and Gross Margin (2017-2022)
7.9 Southeast Asia Insulin Glargine Sales, Revenue, Price and Gross Margin (2017-2022)
7.10 Latin America Insulin Glargine Sales, Revenue, Price and Gross Margin (2017-2022)
7.11 Middle East and Africa Insulin Glargine Sales, Revenue, Price and Gross Margin (2017-2022)
8 Global Insulin Glargine Market Forecast (2022-2029)
8.1 Global Insulin Glargine Sales, Revenue Forecast (2022-2029)
8.1.1 Global Insulin Glargine Sales and Growth Rate Forecast (2022-2029)
8.1.2 Global Insulin Glargine Revenue and Growth Rate Forecast (2022-2029)
8.1.3 Global Insulin Glargine Price and Trend Forecast (2022-2029)
8.2 Global Insulin Glargine Sales and Revenue Forecast, Region Wise (2022-2029)
8.2.1 United States Insulin Glargine Sales and Revenue Forecast (2022-2029)
8.2.2 Europe Insulin Glargine Sales and Revenue Forecast (2022-2029)
8.2.3 China Insulin Glargine Sales and Revenue Forecast (2022-2029)
8.2.4 Japan Insulin Glargine Sales and Revenue Forecast (2022-2029)
8.2.5 India Insulin Glargine Sales and Revenue Forecast (2022-2029)
8.2.6 Southeast Asia Insulin Glargine Sales and Revenue Forecast (2022-2029)
8.2.7 Latin America Insulin Glargine Sales and Revenue Forecast (2022-2029)
8.2.8 Middle East and Africa Insulin Glargine Sales and Revenue Forecast (2022-2029)
8.3 Global Insulin Glargine Sales, Revenue and Price Forecast by Type (2022-2029)
8.3.1 Global Insulin Glargine Revenue and Growth Rate of Vials (2022-2029)
8.3.2 Global Insulin Glargine Revenue and Growth Rate of Cartridges (2022-2029)
8.3.3 Global Insulin Glargine Revenue and Growth Rate of Prefilled Filled Syringe (2022-2029)
8.4 Global Insulin Glargine Consumption Forecast by Application (2022-2029)
8.4.1 Global Insulin Glargine Consumption Value and Growth Rate of Type 1 Diabetes Treatment (2022-2029)
8.4.2 Global Insulin Glargine Consumption Value and Growth Rate of Type 2 Diabetes Treatment (2022-2029)
8.5 Insulin Glargine Market Forecast Under COVID-19
9 Industry Outlook
9.1 Insulin Glargine Market Drivers Analysis
9.2 Insulin Glargine Market Restraints and Challenges
9.3 Insulin Glargine Market Opportunities Analysis
9.4 Emerging Market Trends
9.5 Insulin Glargine Industry Technology Status and Trends
9.6 News of Product Release
9.7 Consumer Preference Analysis
9.8 Insulin Glargine Industry Development Trends under COVID-19 Outbreak
9.8.1 Global COVID-19 Status Overview
9.8.2 Influence of COVID-19 Outbreak on Insulin Glargine Industry Development
10 Research Findings and Conclusion
11 Appendix
11.1 Methodology
11.2 Research Data Source
Global Metformin Hydrochloride Market Research Report 2024
Published: 08-Jan-2024 Price: US 2900 Onwards Pages: 104
Metformin hydrochloride is The raw material of finished product metformin hydrochloride drugs. That is The API metformin hydrochloride. Metformin Hydrochloride finished product is an oral antihyperglycemic drug used in The management of type 2-diabetes. Metformin hydrochloride (N, N-dimethylimidodicarbonimidic diamide hydrochloride) is not chemically or pharmacologically related to any other classes of oral antihyperglycemic agents.
Metformin hydrochloride is a white to off-white crystall......
Global Antidiabetic Sulphonylureas Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 04-Jan-2024 Price: US 3380 Onwards Pages: 112
Market Overview of Global Antidiabetic Sulphonylureas market:
According to our latest research, the global Antidiabetic Sulphonylureas market looks promising in the next 5 years. As of 2022, the global Antidiabetic Sulphonylureas market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of t......
Global Insulin Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 101
According to our LPI (LP Information) latest study, the global Insulin market size was valued at US$ million in 2023. With growing demand in downstream market, the Insulin is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Insulin market. Insulin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization......
Global Insulin API Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 116
According to our LPI (LP Information) latest study, the global Insulin API market size was valued at US$ 1707.6 million in 2023. With growing demand in downstream market, the Insulin API is forecast to a readjusted size of US$ 2101.4 million by 2030 with a CAGR of 3.0% during review period.
The research report highlights the growth potential of the global Insulin API market. Insulin API are expected to show stable growth in the future market. However, product differentiation, reducing co......
Global Glucagon Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 101
According to our LPI (LP Information) latest study, the global Glucagon market size was valued at US$ 543.9 million in 2023. With growing demand in downstream market, the Glucagon is forecast to a readjusted size of US$ 835.7 million by 2030 with a CAGR of 6.3% during review period.
The research report highlights the growth potential of the global Glucagon market. Glucagon are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......
Global Acarbose Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 95
According to our LPI (LP Information) latest study, the global Acarbose market size was valued at US$ 135.8 million in 2023. With growing demand in downstream market, the Acarbose is forecast to a readjusted size of US$ 165.9 million by 2030 with a CAGR of 2.9% during review period.
The research report highlights the growth potential of the global Acarbose market. Acarbose are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......
Global Insulin Glargine Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 77
According to our LPI (LP Information) latest study, the global Insulin Glargine market size was valued at US$ 6562.1 million in 2023. With growing demand in downstream market, the Insulin Glargine is forecast to a readjusted size of US$ 8722.5 million by 2030 with a CAGR of 4.1% during review period.
The research report highlights the growth potential of the global Insulin Glargine market. Insulin Glargine are expected to show stable growth in the future market. However, product differen......
Global Liraglutide Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 103
According to our LPI (LP Information) latest study, the global Liraglutide market size was valued at US$ million in 2023. With growing demand in downstream market, the Liraglutide is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Liraglutide market. Liraglutide are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply ch......
Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 96
According to our LPI (LP Information) latest study, the global Glucagon Like Peptide-1 (GLP-1) Agonists market size was valued at US$ 8624.4 million in 2023. With growing demand in downstream market, the Glucagon Like Peptide-1 (GLP-1) Agonists is forecast to a readjusted size of US$ 21310 million by 2030 with a CAGR of 13.8% during review period.
The research report highlights the growth potential of the global Glucagon Like Peptide-1 (GLP-1) Agonists market. Glucagon Like Peptide-1 (GL......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
